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Summary 24 
Objective: 25 
The effect of quality improvement measures on performance of diagnostic tuberculosis 26 
laboratories in low- and lower-middle income countries is currently unknown and is the subject 27 
of this review.  28 
Methods: 29 
Three databases were searched for quality improvement studies presenting data on performance 30 
parameters before and after the implementation of quality improvement interventions. 31 
Results: 32 
A total of 21 studies were included in this review. Quality improvement measures were most 33 
frequently implemented by an external organization; settings targeted ranged from microscopy 34 
centers, hospitals, districts, regional and national reference laboratories. Quality improvement 35 
interventions and outcome measurements were highly heterogeneous. Most studies investigated 36 
interventions aimed at improving smear microscopy (n=17). Two studies evaluated 37 
comprehensive quality improvement measures (n=2) and another three studies focused on 38 
mycobacterial culture and drug susceptibility testing. Most studies showed an improvement in 39 
outcomes measured in a before-after or time trend analysis. 40 
Conclusion: 41 
Quality improvement measures implemented in tuberculosis laboratories showed a positive 42 
impact on various outcomes. Due to high heterogeneity of outcome reporting and interventions 43 
and the low quality of studies the effect size is unclear. Identification of standardized quality 44 
indicators and their link to quality of patient care would improve knowledge in this field. 45 
  46 
Introduction 47 
Worldwide, an estimated 10.4 million new tuberculosis cases occurred in 2015; a third remained 48 
undiagnosed.1 Accurate, rapid diagnosis is critical for timely initiation of treatment and, 49 
ultimately, disease control. Today quality assurance (QA) is an essential for the diagnostic 50 
process. It comprises activities that enable the achievement and maintenance of high levels of 51 
proficiency and accuracy in laboratory testing2 and includes staff training, quality control (QC), 52 
external and internal quality assessment (EQA and IQA) of laboratory proficiency, quality 53 
performance indicator monitoring and continuous quality improvement. Continuous quality 54 
improvement is a comprehensive management philosophy which employs scientific methods to 55 
increase knowledge and control on work processes variability3 with the goal of customer 56 
satisfaction. EQA and IQA comprise systems aiming to continuously improve reliability and 57 
efficiency of laboratory processes.4 Generally QA is the process of managing for quality, a 58 
strategy of prevention with focus on planning and documenting. QC on the other side is aimed at 59 
verifying the quality of the output, a strategy of detection including all activities designed to 60 
determine the level of quality. All these elements are managed by the quality management 61 
system (QMS) that documents processes, procedures and responsibilities for achieving quality 62 
policies and objectives that is critical for guiding laboratories towards international 63 
accreditation.5   64 
In 2008, the need to expand and strengthen laboratory capacity was acknowledged by the World 65 
Health Organization (WHO) together with multiple international partners.6 This was swiftly 66 
followed by Strengthening Laboratory Management Toward Accreditation (SLMTA) launched 67 
in 2009.7-9  SLMTA is a large-scale effort aimed at improving the quality of laboratory services 68 
and patient care in resource-limited settings by developing a cadre of competent laboratory 69 
managers. The program seeks to engage laboratories in continuous quality improvement and 70 
accelerate their preparations toward accreditation to international standards. WHO has also 71 
developed a framework for targets and indicators for laboratory strengthening as part of the “End 72 
TB Strategy”, which includes indicators for EQA and implementation of QMS.10 Although there 73 
has been progress towards the implementation of QMS in the African Region, more than 90% of 74 
National Tuberculosis Reference Laboratories (NRLs) are not yet accredited.11   75 
However, whether quality improvement measures impact on quality outputs of tuberculosis 76 
laboratories in low- and lower-middle income countries12 is currently unknown and subject of 77 
this review.  78 
 79 
Methods 80 
Studies were selected if they were conducted in tuberculosis laboratories or microscopy centers 81 
from low- and lower-middle income countries12 and evaluated the implementation of QMS, their 82 
components, or more general interventions (such as training, competency checks, EQA with 83 
feed-back loops, etc.) using a comparator (either the same laboratory in a before/after 84 
comparison or other laboratories). Outcomes were extracted as defined by the authors. 85 
MEDLINE, EMBASE and Web of Science were searched up to the 27th week of 2017 using a 86 
compound search strategy (Table S2). The results were cross-referenced with the list of low and 87 
lower-middle income countries from the World Bank from 2016.12 No language restriction was 88 
applied. 89 
Articles identified were imported in the bibliographic software manager EndNoteTM X7. Titles 90 
and abstracts were then screened for eligibility by KK and IDO. Full texts of eligible articles 91 
were retrieved and eligibility criteria applied (KK and IDO). Due to the variability in 92 
intervention and outcomes a narrative approach was taken. Data extraction was performed using 93 
standardized tables. Quality was assessed using a modified Newcastle Ottawa scale (Table S3).13 94 
Meta-analysis was deemed inappropriate due to the heterogeneity in interventions and outcome 95 
measurements. Ethics approval was not required. 96 
 97 
Results 98 
Characteristics of the identified studies 99 
971 unique citations were identified and screened, 78 were selected for full-text review and 21 100 
were retained for further analysis (Figure 1). The majority of studies were conducted in India 101 
(n=5)14-18 and Ethiopia (n=4),19-22 the remaining were from the Democratic Republic of the 102 
Congo,23 Ghana,24 Kenya,25 Malawi,26 Mozambique,27 Nigeria (n=2),28, 29 Sierra-Leone,30 and 103 
Uganda (n=2) (Table 2).31, 32 Two studies reported data from multiple countries including 48 104 
African countries33 and 7 countries and regions from Europe, Africa, and the Middle East.34 The 105 
number of participating laboratories ranged from one to 956. 106 
Settings ranged from microscopy centers, hospitals, district, regional laboratories and NRLs. The 107 
implementing agency in most studies was an external organization, usually the national or 108 
regional reference laboratory. International partner organizations were often involved and 109 
supported the national implementing authority21, 25, 27, 31 or were the sole implementers.19 Three 110 
studies described quality improvement interventions implemented by laboratories themselves.25, 111 
26, 32 Two multisite, multinational studies investigated the effect of EQA schemes with feedback 112 
loops and troubleshooting on subsequent EQA results. Participants were NRLS and research 113 
laboratories.33, 34 114 
Quality improvement interventions consisted of EQA schemes with feedback loops, supervisory 115 
visits conducted by an external agency, implementation of internal quality assurance (IQA), 116 
development of standard operating procedures (SOPs) and staff training. EQA comprised the 117 
evaluation of a lower-level laboratory or microscopy center by a higher-level laboratory (usually 118 
a regional, national or international organization), while IQA consisted of self-implemented 119 
measures within the laboratory with the aim of improving performance.  In most studies, 120 
laboratories underwent repeated rounds of assessment at regular time intervals. Three studies 121 
presented laboratory assessment data obtained before and after implementation of interventions 122 
and comprised two evaluation rounds only.14, 23, 27 The following indicators were reported: 123 
checklist or questionnaires scores across different dimensions, quality of AFB smears 124 
(preparation and staining), number and type of smear reading errors (high- or low-grade),4 smear 125 
result concordance between observers (Table 2). Other reported indicators included culture 126 
contamination rates, proficiency of drug susceptibility testing (DST), and consumables wasted.  127 
 128 
Interventions targeting microscopy 129 
The majority of studies investigated interventions aimed at improving AFB smear microscopy 130 
(n=17) with EQA schemes featuring as the most frequent intervention.14-16, 18-24, 26, 28-33 Slide 131 
panels were provided to laboratories as part of microscopy EQA or randomly selected slides 132 
were blindly rechecked. Slide panels sent by the higher-tier laboratories to the lower-tier 133 
facilities aimed to evaluate staining techniques and reading performance. Random blinded-134 
rechecking of slides involved sending a proportion of slides from the lower-tier facility to the 135 
higher-tier laboratory to investigate slide preparation and staining techniques as well as reading 136 
performance. Reading errors were defined as false positive, false negative and quantification 137 
errors. Smear quality was assessed across the following categories: staining, cleanliness, 138 
thickness, size and evenness. Most studies 10/17 reported an improvement in performance,14, 15, 139 
19-22, 24, 26, 28, 32 while the rest showed either no change or the results were difficult to interpret due 140 
to variability.16, 18, 23, 29-31, 33 Although difficult to assess, studies of interventions showing no 141 
improvement had infrequent evaluation visits23, did not provide timely feed-back30, or were 142 
implemented in laboratories with a good baseline performance.18, 33  143 
Three studies evaluated the impact of panel testing EQA schemes. Panels of 5-100 stained or 144 
unstained slides were provided14, 16, 29, 33 and the proportion of errors made were fed back to 145 
participating laboratories. One study showed an improvement with no errors rated as “high-146 
grade” and a decrease in the number of “low-grade” errors following two rounds of EQA.14 A 147 
multi-country study evaluating the laboratory performance for a wide range of infectious 148 
diseases including TB showed stable high overall scores for AFB smear microscopy across all 149 
settings.33 Variable performance across laboratories and times was observed in a study from 150 
India without any clear effect or trend.16 Another study from Nigeria showed an initial increase 151 
in performance followed by a subsequent decrease but the number of slides sent for panel testing 152 
was very small.29 A study conducted in a newly established research biosafety level 3 research 153 
laboratory showed overall excellent performance for microscopy while participating in two 154 
different EQA schemes.32 155 
Nine studies provided data investigating the effect of random blinded rechecking of microscopy 156 
slides. At baseline, the proportion of false positive (0.1%-19%) and false negative errors (0%-157 
21%) varied widely across studies. Post intervention, the proportion of false positive and false 158 
negative errors ranged between 0% to 1.8% and 0% to 3.6%. Six of the nine studies reported an 159 
overall improvement with a decrease in the proportion of false positives 15, 20, 21, 24, 28 and false 160 
negatives.20, 21, 24 Other studies reported a decrease in major errors15, an increase in laboratories 161 
without any errors21 and increased concordance between laboratory staff and supervisors 162 
performing the rechecking was reported.22, 28 Two studies conducted in India and Nigeria showed 163 
a non-significant increase in the proportion of false negative errors.15, 28 Three studies failed to 164 
show any impact.18, 23, 30 Those studies were conducted in India, Sierra-Leone and the 165 
Democratic Republic of Congo and performed 2-12 rounds of random blinded rechecking.  166 
Six studies reported on the effects of random blinded rechecking or slide reevaluation within an 167 
EQA scheme on the quality of AFB smear preparation and staining.21, 22, 24, 26, 28, 30 Quality of 168 
staining improved in five studies21, 22, 24, 26, 28 with 10-20% improvement on quantifiable effect.21, 169 
24, 28 One study from Sierra-Leone failed to show improvement in AFB smear quality, staining 170 
and reading. However, there was delayed feedback of findings to the submitting laboratory. 171 
These results lead to on-site training of staff.30 172 
 173 
Interventions targeting culture and antimicrobial susceptibility testing 174 
A study from Kenya conducted in a district laboratory reported on the implementation of quality 175 
improvement measures initiated by the laboratory management aiming for accreditation. 176 
Analytical SOPs, laboratory policies and a quality manual were developed. Regular analyses of 177 
quality indicators such as contamination frequency were implemented and optimization of 178 
processes was initiated when required. Culture contamination decreased from 15.4% to 5.3% on 179 
solid media and 15.2% to 9.3% in liquid media. External support was provided for conducting 180 
quality audits, implementing the QMS and gaining accreditation.25  181 
A study conducted by the Italian supranational reference laboratory reported the impact of four 182 
rounds of EQA for phenotypic DST involving two low-income countries in Africa and several 183 
laboratories in Europe. Following the first round of EQAs, the results were discussed with the 184 
national reference laboratories. Expert support was provided both remotely and on-site, if 185 
required, to struggling laboratories aimed to address shortcomings and improving performance. 186 
During subsequent EQA rounds, improvement across all performance parameters including 187 
efficiency and reproducibility was recorded.34 Another study from Uganda periodically reviewed 188 
culture contamination rates and implemented corrective measures when targets were not attained. 189 
Additionally, the center participated in EQA schemes for mycobacterial identification and 190 
DST.32  191 
 192 
Comprehensive quality improvement interventions 193 
Studies implementing comprehensive quality improvement measures included on-site 194 
evaluations as part of EQA schemes, supervisory visits, staff training and development and 195 
implementation of SOPs and electronic inventories. Eight studies described on-site evaluation of 196 
laboratories assessing equipment, consumables, procedures, and levels of staff training.14, 17, 19, 21, 197 
23, 24, 27, 31 Results of evaluation visits were systematically reported back. Additionally, 198 
laboratories were supported to address shortcomings. Site visits were documented using 199 
standardized checklists and questionnaires in six studies.14, 17, 19, 23, 27, 31 One study assessed the 200 
extent and accuracy of data documentation during site vists24, while one study assessed the levels 201 
of theoretical and practical knowledge of staff.23 All studies reported improvement in the 202 
checklist scores, decreased number of recommendations made over time and enhanced 203 
documentation practices.14, 17, 19, 24, 27, 31 One study implemented an electronic inventory system to 204 
enable real-time control of stock, facilitate procurement and check product expiry dates.25 This 205 
decreased expenses due to product expiry from 6% to 1%. Another study reported on the 206 
implementation of a QMS at the NRL. The interventions comprised intensive staff training and 207 
mentoring to strengthen local capacity building. The SLIPTA checklist comprising over 250 208 
items was used for outcome assessment.35 The interventions led to a significant increase in 209 
checklist scores and from zero to a three-star rating.27 Two studies conducted site visits, but did 210 
not report findings.21, 23 211 
 212 
Quality of included studies 213 
Nine studies were marked as moderate quality and twelve studies as low quality (Table 3). This 214 
was mostly due to the study design, lack of evaluation of secular trends, relatively short follow-215 
up time in some studies and uncertainties concerning completeness of follow-up data. 216 
 217 
Discussion 218 
The results of this review suggest a measurable impact of quality improvement measures across 219 
different settings, analytic processes and interventions in tuberculosis laboratories in low- and 220 
lower-middle income countries. Unfortunately, results do not allow firm conclusions regarding 221 
effectiveness of specific interventions as both interventions and outcome measures were highly 222 
heterogeneous. Furthermore, only one study evaluated the effect of implementing a 223 
multicomponent QMS eventually resulting in accreditation of the laboratory.25 The majority of 224 
studies evaluated a single component of a QMS, most frequently EQAs15-18, 20, 22, 28-30, 33, 34 or 225 
aimed at improving a specific process for example documentation.24 Additionally, the feedback 226 
following evaluation and the corrective measures were poorly described. 227 
The SLMTA program was recently introduced with the scope of improving quality in 228 
laboratories in low-resource settings ultimately aiming to facilitate laboratory accreditation. In a 229 
study including more than 600 laboratories across 47 countries in Africa, Asia, the Americas, 230 
SLMTA led to a substantial increase in laboratory performance and quality measured by a 231 
standardized checklist score. Although, this program was not specifically targeted at tuberculosis 232 
laboratories, it shows that training and mentoring of laboratory managers is highly effective in 233 
improving quality. In spite of these encouraging findings, only a small fraction of less than 1% of 234 
participating laboratories completed accreditation.36 Unfortunately, laboratories in countries with 235 
high prevalence of multi-drug resistant (MDR)-tuberculosis such as some countries in Central-236 
Asian were not included. Tuberculosis laboratories are key to MDR-tuberculosis diagnosis and 237 
treatment as results of first and second line DST are vital in guiding MDR-tuberculosis 238 
treatment. Therefore, TB laboratories in high MDR-tuberculosis-burden countries should be a 239 
priority for quality improvement.  240 
Until recently AFB smear microscopy was the main tuberculosis diagnostic in low- and lower-241 
middle income countries. Thus, quality improvement has largely focused on microscopy. 242 
National EQA schemes for microscopy as recommended by WHO37 have been rolled out across 243 
many countries. It is therefore not surprising that the majority of studies included in this review 244 
investigated the effect of microscopy EQA schemes. Reassuringly these schemes had a positive 245 
effect. However, more comprehensive quality improvement measures are needed if broader 246 
culture and molecular diagnostic coverage is to succeed at least in regions with high MDR-247 
tuberculosis prevalence, ultimately aiming to attain the indicators for laboratory strengthening 248 
proposed by the WHO.10 This could include comprehensive interventions targeted at analytic 249 
tests other than microscopy, such as mycobacterial culture, drug susceptibility testing and 250 
molecular techniques. In addition, rather than focusing on individual diagnostic assays, 251 
introduction of a quality management system which also manages areas such as staff, safety, 252 
procurement, pre- and post-analytic processes to name a few should be the ultimate aim. 253 
The review highlights high heterogeneity of outcome measures. Ideally, outcome measures 254 
should be standardized to enable comparison across studies. The SLMTA checklist score 255 
provides such a standardized tool. However, completing the comprehensive checklist is time-256 
consuming and requires expertise. This might impede its widespread use in future studies. A 257 
simpler and user-friendlier tool might be more appropriate. Alternatively, independent external 258 
assessors trained in tuberculosis diagnostics, QMS and ISO 15189 and 17043 standards should 259 
be considered to assess outcomes comprehensively. Other important outcome measures and 260 
quality performance indicators such as turn-around times, service interruptions, specimen 261 
rejection rates, QC results, cost-effectiveness and laboratory staff productivity5 were not reported 262 
in any of the studies included in this review. Furthermore, the cost-effectiveness of implementing 263 
the additional step for attaining accreditation needs to be investigated. Additionally, standardized 264 
reporting on results of quality improvement projects should be attempted.38  265 
The strengths of this review are its comprehensive search strategy across multiple databases and 266 
inclusion of all studies irrespective of language or year of publication. This review is limited by 267 
the small number of countries included. No studies from the Americas or Asia (except for India) 268 
could be identified. The large heterogeneity in interventions and outcomes prohibited 269 
comparisons across studies and meta-analysis. All studies had a before-and-after design. No 270 
study was identified using more stringent study designs such as quasi-experimental studies or 271 
cluster randomized controlled trials. Outcomes were often poorly defined and the quality of most 272 
studies was rated low.  273 
In summary, this review shows that implementation of quality improvement measures in 274 
tuberculosis laboratories in low resources settings improves laboratory performance. Firm 275 
conclusions with regards to the effect size and the most important aspects of the interventions 276 
cannot be drawn due to high heterogeneity of outcomes and interventions and the overall low 277 
quality of studies. Recently, there have been extensive investments in laboratory QMS. This 278 
should be accompanied by research to investigate the impact of QMS interventions and their 279 
cost-effectiveness. Rather than performing before-after studies at one site, a multi-site cluster 280 
randomized trials design should be adopted.  281 
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Figure 1. PRISMA Flow diagram of study selection 294 
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Table 1. Study characteristics – Setting and implementing agencies 296 
Author (year) 
Years the study 
was conducted 
Country 
Type of laboratory(ies), centres, 
setting 
Number of 
laboratories 
Implementing agency 
Addo (2006) 2000-2002 Ghana District laboratories from the 
Greater Accra Region 
12 
NRL 
Audu (2014) 2009-2011 Nigeria Local laboratories from different 
regions, national coverage 
44 
National Institute of Medical Research 
Aziz (2002) 1997-1998 Uganda Microscopy centers from six pilot 
districts, regional 
48 
NTP, international partner 
Fattorini (2008) 2002-2006 Albania, Bahrain, 
Kosovo, Mozambique, 
Oman, Qatar, Turkey 
NRLs 
7 
SRL 
Frean (2012) 2005-2009 48 African countries NRLs, laboratories at tertiary 
hospital, research laboratories 
68 
WHO 
Kumar (2009) 2005-2008 India RRL from nine states 9 NRL 
Malik (2011) 2006-2007 India Microscopy centers from one state 
in India 
183 
RRL 
Marinucci (2013) 2009-2011 Ethiopia Microscopy centers, regional 6 International partner 
Melese (2016) 2011-2015 Ethiopia Microscopy centers, regional 956 NRL, international partner  
Misganaw (2016) 2012-2013 Ethiopia Microscopy centers and hospital 33 NTP 
laboratories from Addis Ababa 
Mundy (2002) 1997-1999 Malawi District laboratory 
1 
Self-implemented/ international organizations for 
EQA 
Musau (2015) 2011-2013 Kenya Research laboratory 
1 
Self-implemented, National Medical Research 
Center, international partner 
Paramasivan (2003) 1998-2000 India RRL from seven states 8 NRL 
Patel (2012) 2005-2010 India District laboratories from one state 29 RRL 
Sarkinfada (2009) 2005-2006 Nigeria Microscopy centers from one state 5 Laboratories at secondary and tertiary hospitals 
Selvakumar (2003) 1999-2001 India Microscopy centers, regional 12 District laboratory 
Shargie (2005) 2000-2002 Ethiopia Microscopy centers from one state 167 RRL, NRL 
Skaggs (2016) 2011-2012 Mozambique NRL 1 National Ministry of Health, international partner  
Ssengooba (2015) 2010-2012 Uganda University hospital research 
laboratory 
1 
National TB Reference Laboratory/ self-
implemented 
Sticht-Groh (1993) 1990-1992 Sierra-Leone District laboratories 10 SRL 
Van Rie (2008) NR Democratic Republic 
of Congo 
Microscopy centers from Kinshasa 
13 
NRL 
NRL=National Reference Laboratory, NTP= National TB Program, RRL= Regional Reference Laboratory, SRL=Supranational Reference Laboratory, WHO= 297 
World Health Organization 298 
299 
Table 2 – Interventions and outcomes of quality improvement measures 300 
Author 
(year) 
Intervention 
Procedures 
targeted 
Methods to assess 
outcomes  
Number, 
periodicity, 
approach  
Outcome 
measurements 
Results 
Overall impact 
of intervention 
Addo 
(2006) 
1.  EQA with 
feedback 
loop 
2.  
Supervisory 
visits   
3.  Training 
4.  IQA 
5.  SOPs 
 
Equipment 
Consumable
s Procedures 
Training 
On-site evaluation: 
laboratory checklist 
Direct observation 
of procedures 
7 EQA rounds 
Quarterly SVs 
Prompt feedback 
provided 
Results of blinded-
rechecking discussed 
with staff 
Documentation Improved documentation practices 
  
Positive  
Microscopy  
 
Random blinded 
re-checking of 
slides 
Direct observation 
of staining 
Error rates 
Slide labelling and 
storage 
Slide preparation 
Quality of slides 
Decrease in error rates (false positives 15% to 
0%, false negatives 21% to 0%) 
Improved slide labelling, cleaning and storage 
Improved smear preparation (10-20% increase 
across all quality parameters) 
Positive  
Audu 
(2014) 
1. EQA with 
feedback 
loop 
2. Training 
3. Provision of 
procedural 
Microscopy Panel testing 4 quarterly rounds of 
5 unstained slides 
Identification of 
slide status 
(positive/ negative) 
and quantification 
Initial improvement of overall scores (from 
42% to 78%), decrease in false negatives 
(from 28% to 4%) and increase in incorrect 
grading of smears (from 64% to 96%) in the 
second round followed by decrease in overall 
scores in the subsequent rounds (to 55% and 
Mixed  
instructions 34% in the third and fourth rounds). 
Aziz 
(2002) 
4. Supervisory 
visits  
 
 
Equipment, 
Consumable
s, 
Procedures 
On-site evaluation: 
laboratory checklist  
Direct observation 
of procedures  
5 EQA rounds 
Quarterly SVs 
(5 rounds) 
Checklist score Improvement in all checklist items 
 
 
Positive  
Microscopy Direct observation 
of microscopy 
procedures and 
reading 
Slide preparation 
and reading 
Not reported Uncertain  
Fattorin
i (2008) 
1. EQA with 
feedback 
loop 
2. Supervisory 
visits  
Drug 
susceptibilit
y testing 
EQA results 4 EQA rounds 
Results discussed 
with laboratory 
director  
SVS conducted when 
required 
Performance and 
reproducibility of 
drug susceptibility 
testing. 
Improvement of all performance parameters 
including efficiency and reproducibility 
Positive  
Frean 
(2012) 
1. EQA with 
feedback 
loop 
2. Supervisory 
Smear 
staining and 
microscopy 
EQA results (panel 
testing) 
3 EQA rounds per 
year over 5 years 
Implementation of 
corrective measures 
Performance of 
smear microscopy 
Stable 85% acceptable scores, no 
improvement during the evaluation period. 
No change 
visits 
3. Training 
sole responsibility of 
laboratory staff 
Kumar 
(2009) 
1. EQA with 
feedback 
loop 
2. Supervisory 
visits  
3. Training   
Equipment, 
Consumable
s, 
Procedures 
Training 
On-site evaluation 
using a checklist  
2 EQA rounds 
2 SVs 
Number of 
recommended 
actions  
Evaluation of 
checklist items 
 
Improvement of facilities, infrastructures and 
human resources.  
Increase in the number of staff trained in EQA 
(from 42% to 55%).  
Fewer recommended actions recommended 
during follow-up visits 
Overall improvement of checklist items  
Positive  
Microscopy  
 
EQA results (on-
site panel testing) 
Number and type 
of errors 
Improved performance (no high-grade false 
results during the follow-up visit)  
Decrease in number of low-grade false results. 
Positive  
Malik 
(2011) 
1. EQA with 
feedback 
loop 
Microscopy Random blinded 
rechecking of 
slides  
monthly EQA rounds 
Monthly SVs over 2 
years 
Feedback of number 
and type of errors and 
suggestions for 
improvement 
Number and type 
of errors 
Decrease in the number of major errors by 
29%. Decrease in the number of high false-
positive results by 64%.  
Slight increase in the number of high false 
negative errors (by 20%) 
Positive  
Marinuc 1. EQA with Microscopy On-site evaluation 4-6 EQA rounds Questionnaire Decrease in centers with inadequate Positive  
ci 
(2013) 
feedback 
loop 
2. Supervisory 
visits 
3. Training   
for TB and 
malaria 
using questionnaire  
 
Quarterly SVs 
High turnaround time 
for feedback 
score performance from 5/6 at baseline to 0/6.  
Improvement in score for all sections of the 
questionnaire 
Melese 
(2016) 
1. EQA with 
feedback 
loop 
2. Supervisory 
visits   
3. Training 
4. IQA  
Equipment, 
Consumable
s, 
Procedures 
Training  
On-site evaluation: 
direct observation 
of procedures, 
consumables, data 
documentation  
Quarterly SVs NR NR Uncertain  
Microscopy Random blinded 
rechecking of 
slides  
 
11 EQA rounds Number of errors. 
Smear and staining 
quality 
Decrease in false positive rates from 0.6% to 
0.2% Decrease in false negative results from 
7.6% to 1.6% 
Increase in the proportion of centers with no 
errors from 78% to 91% 
Increase in quality of staining from 71% to 
81% Improvement in other smear quality 
parameters  
Positive  
Misgan
aw 
1. EQA with 
feedback 
Microscopy Random blinded 
rechecking of 
7 EQA rounds 
Quarterly SV 
Evaluation of 
smear quality 
Increase in smear quality 
Decrease in the number of discordant results 
Positive  
(2016) loop  
2. Training  
slides  
 
Regular feedback 
provided and 
corrective measures 
discussed 
Discordant results 
Number of errors 
Mundy 
(2002) 
3. IQA 
4. EQA with 
feedback 
loop   
Microscopy  Random blinded 
re-checking as part 
of IQA 
Evaluation of 
specimen 
suitability, smear 
preparation, 
staining and 
reading. 
Specimen labeling 
NR Sample labelling 
and staining 
Proportion of 
discordant results 
(not reported as 
before and after) 
Increase in the number of samples labelled 
correctly from 31% collected at health centers 
and -80% collected at the hospital to 100%. 
Improvement in staining techniques 
Positive  
Musau 
(2015) 
1. IQA 
2. EQA with 
feedback 
loop   
3. Training 
4. SOPs 
Consumable
s, 
Procedures 
Training  
Calculation of 
costs for expired 
products 
Electronic 
inventory system 
issuing alerts for 
NR Waste from 
product expiry 
Client satisfaction 
Accreditation  
Decrease in expenditures due to product 
expiry from 6.1% to 1.3% 
Client satisfaction of 98% 
Accreditation of laboratory 
High EQA pass results (90-100%) for 
microscopy, culture, DST and Xpert. 
Positive  
5. Electronic 
inventory 
expired products 
and items requiring 
re-ordering 
Culture  Evaluation of 
culture 
contamination 
 Culture 
contamination rates 
for solid and liquid 
media 
Decrease in contamination rates for solid 
media from 15% to 5% and for liquid media 
from 15% to 9%  
Positive  
Paramas
ivan 
(2003) 
1. EQA with 
feedback 
loop   
Microscopy Panel testing of 
slides 
5 EQA rounds Proportion and 
type of errors 
Concordance 
between 
technicians 
Variable levels of performance and 
consistency during the evaluation rounds 
Uncertain  
Patel 
(2012) 
1. EQA with 
feedback 
loop 
2. Supervisor
y visits 
3. IQA 
4. SOPs 
Infrastructur
e, 
Equipment, 
Consumable
s, 
Procedures. 
Training 
On-site evaluation: 
checklist-based  
 
3 EQA rounds 
3 SVs 
Checklist scores Improvement in scores for all categories.  
Overall increase in scores from 86% to 92%. 
Increase in internal quality control parameters 
from 66% to 93%. 
Positive  
Sarkinfa 1. EQA with Microscopy Random blinded 6 EQA rounds Concordance of Increase in concordance of results from 81% Positive  
da 
(2009) 
feedback 
loop 
2. Staff 
training 
for TB and 
malaria 
re-checking of 
slides 
(comparison between 
baseline and final 
visits only) 
results, 
Reading errors,  
Quality of smear 
preparation and 
staining 
to 91%. Decrease in false positive results from 
19% to 1.8%. Slight increase in false negative 
results from 0% to 3.6% 
Increase in specificity from 80% to 97.9%  
Decrease in sensitivity from 100% to 77.8% 
Increase in the proportion of good smears 
from 38 to 57% and good staining from 48% 
to 59% 
Selvaku
mar 
(2003) 
1. EQA with 
feedback 
loop 
2. Training 
Microscopy Blinded rechecking 
of slides 
12 EQA rounds 
Monthly SVs 
Reading errors Low proportion of false positive results of 0-
1.2% and false negative results of 1.7%-4.7%. 
No clear trend over time. 
Uncertain   
Shargie 
et al. 
1. EQA with 
feedback 
loop 
Microscopy Random blinded 
rechecking of 
slides 
10 EQA rounds 
Quarterly SVs 
Regular feedback 
provided 
Reading errors Decrease in false positive slides from 4.4% to 
1.5%. Decrease in false negative slides from 
3.9% to 2.6%. 
Positive  
Skaggs 
et al 
(2016) 
1. QMS 
2. Staff 
training 
and 
Equipment 
Consumable
s Procedures 
Training 
On site-evaluation, 
checklist (SLIPTA) 
2 EQA rounds Checklist scores Increase in checklist score from 59 to 196 
points (maximum of 250 points). Achieved a 
3-star grading 
Positive  
mentoring 
3. External 
and 
internal 
audits 
Ssengoo
ba 
(2015) 
1. EQA with 
feed-back 
loop 
2. Monitorin
g of 
performan
ce 
indicators 
3. QMS 
Microscopy 
Culture  
Drug 
susceptibilit
y testing 
EQA results 
(participation in 
two EQA schemes) 
Panel testing 
Evaluation of 
culture 
contamination 
9 EQA rounds Performance for 
microscopy and 
drug susceptibility 
testing EQAs  
Culture 
contamination rates 
for solid and liquid 
media (yearly 
reports) 
 
High performance for microscopy EQA of 
100% with a decrease to 83% at the end of the 
evaluation period 
Increase in performance of drug susceptibility 
testing from 89% to 100% for isoniazid, from 
78% to 100% for rifampicin and from 78%% 
to 90% for ethambutol. Decrease for 
streptomycin from 100% to 90% 
Variable contamination rates between 1.8-
5.5% for LJ and 8.2-26.1% for MGIT 
Positive  
Sticht-
Groh 
(1993) 
1. EQA  Microscopy Blinded rechecking 
of slides 
Evaluation of 
smear quality and 
staining 
8 EQA rounds Reading errors 
Quality of smear 
preparation and 
staining 
No improvement in smear quality or staining. 
No improvement in the performance of slide 
reading 
(training of local staff was initiated following 
results) 
No change 
Van Rie 
(2008) 
1. EQA with 
feedback 
loop 
2. Supervisor
y visits 
3. Training 
4. Provision 
of 
equipment 
(microscop
es) 
Equipment 
Consumable
s 
Procedures 
Training 
On-site evaluation 
using a checklist 
2 SVs (9 months 
apart) 
Outline of corrective 
actions 
Delayed feedback to 
lower-tier centers 
Checklist score 
Evaluation of 
knowledge and 
skills of 
technicians 
Improvement of practical skills in smear 
preparation, staining and reading following 
training (increase in score from 70% to 86%). 
Increase in knowledge of technicians of 
theoretical aspects of TB diagnosis (increased 
score from 89% to 92%). 
Positive 
Microscopy Random blinded 
rechecking 
 
 Reading errors 
 
No improvement in the number of errors 
(major errors were present in 8/13 laboratories 
before the intervention and in 10/13 centers 
after the intervention).  
No change in the proportion of laboratories 
with minor errors 
No change  
EQA= external quality assessment; IQA= internal quality assessment; NR= not reported; SV = supervisory visits, SOP= standard operating procedures. 301 
  302 
 303 
Table 3: Summary of quality assessment of included studies 304 
Author (year) 
Selection Comparability* Outcome 
Total 
Quality of 
evidence 1 2 1 1 2 3 
Addo (2006) 1 2 0 1 1 0 5 Low 
Audu (2014) 1 2 0 2 0.5 1 6.5 Moderate 
Aziz (2002) 1 2 0 1 0.5 0 4.5 Low 
Fattorini (2008) 2 2 0 2 1 1 8 Moderate 
Frean (2012) 2 2 0 1.5 1 0 6.5 Moderate 
Kumar (2009) 2 1 0 0.5 0 0 3.5 Low 
Malik (2011) 2 2 0 2 2 0 8 Moderate 
Marinucci (2013) 1 2 0 1 1 1 6 Low 
Melese (2016) 2 1 0 1 2 0 6 Low 
Misganaw (2016) 1 2 0 2 1 0 6 Low 
Mundy (2002) 1 2 0 1 0 2 6 Low 
Musau (2015) 1 2 0 1 2 2 8 Moderate  
Paramasivan (2003) 2 2 0 1.5 1 2 8.5 Moderate 
Patel (2012) 2 2 0 2 1 0 7 Moderate 
Sarkinfada (2009) 1 2 0 2 1 2 8 Moderate  
Selvakumar (2003) 1 2 0 2 1 0 6 Low 
Shargie (2005) 1 2 0 2 1 0 6 Low 
Skaggs (2016) 2 2 0 2 0 2 8 Moderate  
Ssengooba (2015) 1 1 0 2 2 0 6 Low 
Sticht-Groh (1993) 1 1 0 1.5 1 0 4.5 Low 
Van Rie (2008) 1 1 0 1 0 2 5 Low  
*None of the studies reported on trends prior to intervention. Quality of evidence: 0-6 points: low; 7-9 points: moderate; 10-12 points: high.  305 
 306 
 307 
 308 
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